
Caranx Medical is a French medical technology company developing the AIIR platform, an advanced robotic surgical system integrating artificial intelligence, image-guided intervention, and robotic assistance to enable autonomous and precise endoluminal procedures under clinician supervision. Their flagship product, TAVIPILOT, is the first robotic solution for optimizing aortic valve implantation, aiming to standardize and democratize complex surgical procedures, reduce risks, and improve patient outcomes. The company is based in Paris and Nice, with a multidisciplinary international team and strong R&D focus. They have achieved significant milestones including the world's first robotic-assisted heart valve implantation in an animal and have submitted their AI software for FDA approval. Their business model is centered on developing innovative surgical robotics technology to broaden access to minimally invasive care globally, addressing the growing demand driven by aging populations and clinician shortages.

Caranx Medical is a French medical technology company developing the AIIR platform, an advanced robotic surgical system integrating artificial intelligence, image-guided intervention, and robotic assistance to enable autonomous and precise endoluminal procedures under clinician supervision. Their flagship product, TAVIPILOT, is the first robotic solution for optimizing aortic valve implantation, aiming to standardize and democratize complex surgical procedures, reduce risks, and improve patient outcomes. The company is based in Paris and Nice, with a multidisciplinary international team and strong R&D focus. They have achieved significant milestones including the world's first robotic-assisted heart valve implantation in an animal and have submitted their AI software for FDA approval. Their business model is centered on developing innovative surgical robotics technology to broaden access to minimally invasive care globally, addressing the growing demand driven by aging populations and clinician shortages.